The BI and CI function has never been more integral to the future of pharma as companies seek the most innovative ways to assess and beat the competition. In order to recapture the days of double digit growth, pharma take a ore streamlined approach to competitive intelligence and business analysis and interpret and communicate this intelligence to aid strategic decision-making, says Binyah Kesselly, Director of Enterprise Improvement and Business Excellence at Johnson & Johnson.
The two day information and networking extravaganza will allow the executives to meet among themselves to further set forth better decision-making processes earlier in clinical development to make more effective pipeline and product decisions and ensure that new product launches are based on the optimal intelligence and the best commercial interest.
Highlights of this conference include the following:
- The Only Annual Conference with all of the top 10 Pharma Companies Present
- Panel of Past SCIP Presidents
- Large Exhibition Of BI, CI and other Business Analysis Service Providers
- Expanded Agenda To Attract Market Research And Business Analysis Executives
- Pre-event Online Social Network â over 300 members already!
The speaking faculty includes a pharmaceutical industry "Who's Who" list of CI, BI and Business Analysis professionals from pharma & biotech include the following companies: Pfizer, Johnson & Johnson, sanofi-aventis, AstraZeneca, Novartis, Alcon Laboratories, Biovail, Daiichi Sankyo, Ortho McNeil Pharmaceutical, Shire Laboratories, ThermoFisher Diagnostics, EFP Markets...
For further information, please visit:
eyeforpharma is a leading global source of information for the pharmaceutical industry. Our reputation has been built on quality, in-depth conferences that have distinguished themselves from competitors by the depth and breadth of research we put into each conference to ensure it is covering the hottest and most pertinent issues of the industry. Months are spent talking directly to senior executives in the industry, as well as relevant consultants and journalists and well respected solutions providers. For more information, please visit www.eyeforpharma.com.